Clinical Trial Update: One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the impact of one or two weeks of methotrexate discontinuation on the efficacy of influenza vaccination in rheumatoid arthritis patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rheumatoid Arthritis, Autoimmune Diseases | Phase 3 | Status: COMPLETED